Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemant Yadav

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Materials (Basel, Switzerland)|February 15, 2022
Enhancement of Vancomycin Potential against Pathogenic Bacterial Strains via Gold Nano-Formulations: A Nano-Antibiotic ApproachTurki Al Hagbani, Hemant Yadav, Afrasim Moin, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2011
Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analoguesMohamed Jawed Ahsan, Jeyabalan Govinda Samy, Savita Soni, et al.
Journal of Translational Medicine|December 2, 2025
Targeting ubiquitin-specific protease 14 reduces metastatic potential and metabolic activity in cervical cancer via direct modulation of monocarboxylate transporter-4Ravi Chauhan, Gunjan Dagar, Lakshay Malhotra, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Materials (Basel, Switzerland)|February 15, 2022
Enhancement of Vancomycin Potential against Pathogenic Bacterial Strains via Gold Nano-Formulations: A Nano-Antibiotic ApproachTurki Al Hagbani, Hemant Yadav, Afrasim Moin, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2011
Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analoguesMohamed Jawed Ahsan, Jeyabalan Govinda Samy, Savita Soni, et al.
Journal of Translational Medicine|December 2, 2025
Targeting ubiquitin-specific protease 14 reduces metastatic potential and metabolic activity in cervical cancer via direct modulation of monocarboxylate transporter-4Ravi Chauhan, Gunjan Dagar, Lakshay Malhotra, et al.
Pageof 2